Inhibition of human immunodeficiency virus type 1 assembly and release by the cholesterol-binding compound amphotericin B methyl ester: evidence for Vpu dependence.
about
Deficiency of niemann-pick type C-1 protein impairs release of human immunodeficiency virus type 1 and results in Gag accumulation in late endosomal/lysosomal compartmentsLipids and membrane microdomains in HIV-1 replicationTetherin restricts direct cell-to-cell infection of HIV-1.Novel approaches to inhibiting HIV-1 replication.Effect of mutations in the human immunodeficiency virus type 1 protease on cleavage of the gp41 cytoplasmic tail.Polarity changes in the transmembrane domain core of HIV-1 Vpu inhibits its anti-tetherin activity.The Role of Lipids in Retrovirus Replication.Cytoplasmic body component TRIM5{alpha} requires lipid-enriched microdomains for efficient HIV-1 restriction.Relationships between plasma membrane microdomains and HIV-1 assemblyHIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation.Polyene antibiotic that inhibits membrane transport proteins.Structural and Molecular Determinants of Membrane Binding by the HIV-1 Matrix Protein.HIV-1 Assembly at the Plasma Membrane: Gag Trafficking and Localization.Amphotericin B Inhibits Enterovirus 71 Replication by Impeding Viral Entry.HIV-1 Vpu antagonizes BST-2 by interfering mainly with the trafficking of newly synthesized BST-2 to the cell surface.Overexpression of inactive tetherin delGPI mutant inhibits HIV-1 Vpu-mediated antagonism of endogenous tetherin.Challenges in HIV and visceral Leishmania co-infection: future research directions.
P2860
Q24644759-19B3D0B3-82A5-401D-AC1A-93151A23B8D4Q27489393-EE5015E9-5BCB-4997-96DD-16E025897E62Q30497822-CF0124E2-C932-4918-852B-77FD67B1A71AQ33624690-74FA5E88-6E7F-49C1-B93F-DC6E57B9BEB4Q33676508-CD4E4273-49F1-48CD-911F-DDD97D0198BDQ33933111-C87319CD-9B8C-469E-8B1F-B2C8C5D46695Q34080779-8A5A4C4B-4C3A-4F21-AD4E-6F0714C99BADQ34251147-17B44CB3-6E73-4650-8218-619C03DD4B69Q34666503-73F4627B-2E34-43D5-93A3-190ED1703048Q35113720-009BF5AC-804D-4306-9EA5-86CB3976CE3DQ36094142-D5FE7437-7B36-457C-AC73-AE18DFE022FBQ36812591-3C0C79E0-9608-45FE-9CB4-854542ADCA3EQ37178360-4A6BB71C-EAF3-4321-B33B-15D95599FB7AQ37243489-42A4D129-2A2E-4ED3-A747-37DFC10D2473Q38281996-28053A3E-72FD-4380-B592-C9DD5E674C70Q43433320-665BBA29-E3F7-48D1-9B18-4C8376602F55Q51800025-944FB62D-90C2-445E-9308-BE207D3E6FDB
P2860
Inhibition of human immunodeficiency virus type 1 assembly and release by the cholesterol-binding compound amphotericin B methyl ester: evidence for Vpu dependence.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Inhibition of human immunodefi ...... : evidence for Vpu dependence.
@en
type
label
Inhibition of human immunodefi ...... : evidence for Vpu dependence.
@en
prefLabel
Inhibition of human immunodefi ...... : evidence for Vpu dependence.
@en
P2093
P2860
P356
P1433
P1476
Inhibition of human immunodefi ...... : evidence for Vpu dependence.
@en
P2093
Abdul A Waheed
Carl P Schaffner
Eric O Freed
Ferri Soheilian
Kunio Nagashima
Sherimay D Ablan
P2860
P304
P356
10.1128/JVI.00917-08
P407
P50
P577
2008-07-23T00:00:00Z